200,000+ products from a single source!
sales@angenechem.com
Home > Quinoline > 161468-32-2
CAS No: 161468-32-2 Catalog No: AG00AB96 MDL No:
| Title | Journal |
|---|---|
| Chorionic gonadotrophin regulates CXCR4 expression in human endometrium via E-series prostanoid receptor 2 signalling to PI3K-ERK1/2: implications for fetal-maternal crosstalk for embryo implantation. | Molecular human reproduction 20110101 |
| β-Adrenergic inhibition of contractility in L6 skeletal muscle cells. | PloS one 20110101 |
| Prostaglandin F(2alpha)-F-prostanoid receptor regulates CXCL8 expression in endometrial adenocarcinoma cells via the calcium-calcineurin-NFAT pathway. | Biochimica et biophysica acta 20091201 |
| Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. | Molecular and cellular endocrinology 20080326 |
| PKC and PKA inhibitors reinstate morphine-induced behaviors in morphine tolerant mice. | Pharmacological research 20061201 |
| Activation of the adenylyl cyclase/protein kinase A pathway facilitates neural release of beta-nicotinamide adenine dinucleotide in canine mesenteric artery. | European journal of pharmacology 20060424 |
| Multiple signalling pathways involved in beta2-adrenoceptor-mediated glucose uptake in rat skeletal muscle cells. | British journal of pharmacology 20060201 |
| Norepinephrine increases glucose transport in brown adipocytes via beta3-adrenoceptors through a cAMP, PKA, and PI3-kinase-dependent pathway stimulating conventional and novel PKCs. | Endocrinology 20040101 |
| The expression of a high level of morphine antinociceptive tolerance in mice involves both PKC and PKA. | Brain research 20030919 |
| Involvement of cyclic AMP-mediated pathway in neural release of noradrenaline in canine isolated mesenteric artery and vein. | Cardiovascular research 20030101 |
| Tonic inhibitory role for cAMP in alpha(1a)-adrenergic receptor coupling to extracellular signal-regulated kinases 1/2. | The Journal of pharmacology and experimental therapeutics 20021001 |
© 2019 Angene International Limited. All rights Reserved.